Observation after Naloxone Administration for Suspected Opioid Overdose

In the systematic review "Do heroin overdose patients require observation after receiving naloxone?", the authors analyzed multiple studies to evaluate the necessity of post-naloxone observation for heroin overdose patients. The review concluded that adverse events following naloxone administration are relatively rare but can occur, emphasizing the importance of initial monitoring.

Key results

• In 5443 patients treated with naloxone by EMS in the field and released without being taken to the hospital, 4 deaths (0.07%) occurred due to rebound opioid toxicity.
• In studies evaluating ED observation, 6–9% of patients required re-administration of naloxone, though most adverse events occurred within the first hour of monitoring.
• Christenson et al. proposed a clinical prediction rule with 99% sensitivity for safely discharging patients after 1 hour if they met the following criteria:
• Normal vital signs.
• Glasgow Coma Scale (GCS) of 15.
• Ability to ambulate normally.

Author conclusions

“Patients revived with naloxone after heroin overdose may be safely released without transport to the hospital if they have normal mentation and vital signs. In the absence of co-intoxicants and further opioid use there is very low risk of death from rebound opioid toxicity. For those patients treated in the ED for opioid overdose, an observation period of one hour is sufficient if they ambulate as usual, have normal vital signs and a Glasgow Coma Scale of 15.”

Critical Appraisal and Analysis

For a detailed analysis, including strengths, limitations, and implications for practice, review these FOAMed resources:

1. Skeptics Guide to EM: Chase the Dragon and Naloxone

The systematic review by Willman et al. has several notable limitations that warrant cautious interpretation of its findings. The included studies were predominantly observational and exhibited significant heterogeneity in patient populations, methodologies, and settings, which limits generalizability. Short-term follow-up and reliance on EMS or medical examiner records may have underestimated delayed or out-of-hospital adverse events, while the grouping of minor and major adverse events diluted the clinical relevance of the outcomes. Additionally, the focus on heroin overdoses, absence of standardized observation protocols, and limited applicability to the evolving opioid epidemic involving synthetic opioids like fentanyl further restrict the utility of the review's conclusions in modern practice.

In the single study, prospective observational validation study "Hospital Observation Upon Reversal (HOUR) With Naloxone", the authors evaluated if patients could be discharged safely following naloxone administration for opiate overdose if they met all the following criteria at the 1-hour mark after naloxone administration:

• Ability to mobilize as usual.
• Normal oxygen saturation (≥95%).
• Respiratory rate between 10 and 20 breaths/min.
• Temperature between 35.0°C and 37.5°C.
• Heart rate between 50 and 100 bpm.
• Glasgow Coma Scale (GCS) of 15.

Key Results

• N = 538 patients who received at least one administration of prehospital naloxone, were transported to the study hospital, and had a 1-hour evaluation performed by a provider.

Metric	Clinical Prediction Rule	Clinical Judgment	Combined
Adverse Events	13 (2.4%)	12 (2.3%)	10 (1.9%)
Sensitivity	84.1% (76.2–92.1%)	85.4% (77.7–93.0%)	87.8% (80.7–94.9%)
Specificity	62.1% (57.6–66.5%)	60.9% (56.3–65.4%)	53.0% (48.4–57.7%)
NPV	95.6% (93.3–97.9%)	95.8% (93.4–98.1%)	96.0% (93.5–98.4%)
PPV	28.5%	28.6%	25.5%

• Adverse Events (AEs) were defined as any of the following within 24 hours
• Death
• Repeat naloxone for respiratory rate ≤ 10 breaths/min or oxygen saturation ≤ 92%
• Delivery of supplemental oxygen for a saturation ≤ 92% Assisted ventilation (including BiPAP)
• Administration of IV inotropic agents
• Administration of antiarrhythmic medications for sustained tachycardia > 130 beats/min
• Cardioversion
• Administration of mannitol Dialysis
• Administration of bicarbonate for HCO3 < 5 mmol/L in ABG or CO2 < 5 mmol/L in VBG
• Critical findings
• 16 patients (3.0%) required repeat naloxone at some point within 24 hours.
• No deaths were reported within 48 hours.

Author conclusions

“This rule may be used to risk stratify patients for early discharge following naloxone administration for suspected opioid overdose.”

Critical Appraisal and Analysis

For in-depth critical appraisal, including strengths, limitations, and caveats, review these FOAMed analyses:

1. First10EM: The HOUR rule for opioid overdose (Clemency 2018)
2. RebelEM: The HOUR Trial: Clinical Decision Rule for Opioid Overdose Patients in the Emergency Department
3. Skeptics Guide to EM: Wake me up Before you go, go – Using the HOUR Rule
4. Tox & Hound: Tox and Hound – Great! Naloxone worked! Now what?

While the HOUR study provides valuable insights, its findings should be applied cautiously due to notable limitations. These include its single-center design, reliance on chart reviews and local medical examiner records (which may miss delayed or out-of-region events), and selection bias from convenience sampling. Furthermore, the inclusion of both clinically significant and minor adverse events in the composite outcome, along with the lack of blinding, limits the study's generalizability and clinical applicability.

In the single center retrospective review "Need for Delayed Naloxone or Oxygen in Emergency Department Patients Receiving Naloxone for Heroin Reversal", the authors assessed the safety of a 2-hour ED observation period for heroin overdose patients treated with naloxone. They evaluated the delayed need for repeat naloxone or supplemental oxygen as markers of intervention after the observation period.

Key Results

• Study Population: 806 visits from 713 patients with heroin overdose treated with naloxone at a single urban Level I trauma center.
• Primary Outcome:
• 4.6% (37 patients) required an intervention (repeat naloxone or oxygen) after 2 hours.
• Intervention rates dropped to 1.9% at 3 hours and 0.9% at 4 hours.
• Interventions:
• 29 patients (3.6%) required repeat naloxone after 2 hours.
• 17 patients (2.0%) required supplemental oxygen after 2 hours.
• High-Risk Factors:
• Patients with polysubstance use were significantly more likely to require repeat naloxone (p < 0.01).

Author conclusion

"A 2-hour ED observation period for heroin overdose patients after naloxone administration resulted in a delayed intervention rate of almost 5%. Clinicians may consider a 3-hour observation period for additional safety, particularly for patients with polysubstance use."

Critical Appraisal and Analysis

For a detailed analysis, including strengths, limitations, and implications for practice, review these FOAMed resources:

1. RebelEM: Heroin OD – Is a 2-Hour Observation Protocol Long Enough?

The Heaton et al. study provides insights into the safety of a 2-hour observation protocol following naloxone administration for heroin overdose, but several limitations warrant caution in applying its findings. These include its retrospective design, reliance on incomplete data (e.g., self-reported substance use and variable toxicology screening), and potential inaccuracies in observation timing due to prehospital naloxone administration. Additionally, the study's focus on heroin overdoses limits its applicability to polysubstance use and synthetic opioids, while physician-dependent outcome measures and the lack of detailed subgroup analysis further restrict generalizability. These limitations underscore the need for prospective research to validate the findings and refine observation protocols for diverse patient populations.

Discharge decisions after naloxone administration should prioritize individualized patient safety. While structured prediction tools and observation protocols can guide decision-making, the evolving opioid landscape, particularly with synthetic and long-acting opioids, underscores the need for further research to develop robust, evidence-based discharge practices.

1. Willman MW, Liss DB, Schwarz ES, Mullins ME. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16. PMID: 27849133.
2. Clemency BM, Eggleston W, Shaw EW, Cheung M, Pokoj NS, Manka MA, Giordano DJ, Serafin L, Yu H, Lindstrom HA, Hostler D. Hospital Observation Upon Reversal (HOUR) With Naloxone: A Prospective Clinical Prediction Rule Validation Study. Acad Emerg Med. 2019 Jan;26(1):7-15. doi: 10.1111/acem.13567. Epub 2018 Dec 28. PMID: 30592101.
3. Christenson J, Etherington J, Grafstein E, Innes G, Pennington S, Wanger K, Fernandes C, Spinelli JJ, Gao M. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med. 2000 Oct;7(10):1110-8. doi: 10.1111/j.1553-2712.2000.tb01260.x. PMID: 11015242.
4. Heaton JD, Bhandari B, Faryar KA, Huecker MR. Retrospective Review of Need for Delayed Naloxone or Oxygen in Emergency Department Patients Receiving Naloxone for Heroin Reversal. J Emerg Med. 2019 Jun;56(6):642-651. doi: 10.1016/j.jemermed.2019.02.015. Epub 2019 Apr 5. PMID: 30961922.